Short Interest in Aethlon Medical, Inc. (NASDAQ:AEMD) Increases By 45.6%

Aethlon Medical, Inc. (NASDAQ:AEMDGet Rating) was the target of a significant growth in short interest during the month of May. As of May 15th, there was short interest totalling 23,000 shares, a growth of 45.6% from the April 30th total of 15,800 shares. Based on an average daily volume of 168,800 shares, the short-interest ratio is currently 0.1 days.

Institutional investors have recently bought and sold shares of the stock. Geode Capital Management LLC grew its holdings in Aethlon Medical by 32.3% during the third quarter. Geode Capital Management LLC now owns 136,451 shares of the medical equipment provider’s stock worth $526,000 after acquiring an additional 33,330 shares during the period. Renaissance Technologies LLC grew its holdings in Aethlon Medical by 377.0% during the fourth quarter. Renaissance Technologies LLC now owns 242,200 shares of the medical equipment provider’s stock worth $450,000 after acquiring an additional 191,425 shares during the period. Dimensional Fund Advisors LP acquired a new stake in Aethlon Medical during the third quarter worth about $397,000. Bank of New York Mellon Corp acquired a new stake in Aethlon Medical during the third quarter worth about $111,000. Finally, Jane Street Group LLC acquired a new stake in Aethlon Medical during the third quarter worth about $101,000. 10.58% of the stock is currently owned by hedge funds and other institutional investors.

Several brokerages have issued reports on AEMD. Maxim Group dropped their target price on Aethlon Medical from $11.00 to $4.00 in a research report on Tuesday, February 15th. StockNews.com began coverage on Aethlon Medical in a research report on Sunday. They issued a “sell” rating on the stock.

AEMD stock opened at $1.47 on Friday. The business’s 50-day moving average price is $1.25 and its 200-day moving average price is $1.63. The stock has a market cap of $22.65 million, a P/E ratio of -2.45 and a beta of 0.81. Aethlon Medical has a twelve month low of $0.88 and a twelve month high of $12.49.

About Aethlon Medical (Get Rating)

Aethlon Medical, Inc, a medical technology company, focuses on developing products to diagnose and treat life and organ threatening diseases in the United States. The company develops Aethlon Hemopurifier, a clinical-stage immunotherapeutic device that removes tumor-derived exosomes and life-threatening viruses from the human circulatory system.

Read More

Receive News & Ratings for Aethlon Medical Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Aethlon Medical and related companies with MarketBeat.com's FREE daily email newsletter.